TG Therapeutics, Inc. (MHA) Announces Third Quarter 2013 Financial Results And Business Update
11/12/2013 12:42:59 PM
NEW YORK, Nov. 11, 2013 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX), an innovative clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced its results for the third quarter ended September 30, 2013 and recent company developments.
Help employers find you! Check out all the jobs and post your resume.